Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.

Multiple sclerosis

Compston, Alastair, Coles, Alasdair · 2002 · The Lancet

Abstract

Multiple sclerosis is the prototype inflammatory autoimmune disorder of the central nervous system and, with a lifetime risk of one in 400, potentially the most common cause of neurological disability in young adults. As with all complex traits, the disorder results from an interplay between as yet unidentified environmental factors and susceptibility genes. Together, these factors trigger a cascade of events, involving engagement of the immune system, acute inflammatory injury of axons and glia, recovery of function and structural repair, post-inflammatory gliosis, and neurodegeneration. The sequential involvement of these processes underlies the clinical course characterised by episodes with recovery, episodes leaving persistent deficits, and secondary progression. The aim of treatment is to reduce the frequency, and limit the lasting effects, of relapses, relieve symptoms, prevent disability arising from disease progression, and promote tissue repair. Despite limited success in each of these categories, everyone touched by multiple sclerosis looks for a better dividend from applying an improved understanding of the pathogenesis to clinical management.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)08220-x

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 78 references

Research works printed but not linked: 7

  1. Homes, 1995, The cost of multiple sclerosis, Br J Med Econ, 18, 181
  2. Sawcer S, Meranian M, Setakis E, et al. A whole genome screen for linkage disequilibirum in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain (in press).
  3. Sriram, 1999, Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis, Ann Neurol, 46, 6, 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M · doi:10.1002/1531-8249(199907)46:1<6::aid-ana4>3.0.co;2-m
  4. Panitch, 1997, Clinical trials of a phase III trial of oral myelin in replacing-remitting multiple sclerosis, Ann Neurol, 42, 459
  5. 2000, Interferon beta-1b in secondary progressive MS: clinical and MRI results of a 3-year randomised controlled trial, Neurology, 54, 2352
  6. Coles, 1999, Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis, Ann Neurol, 46, 296, 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · doi:10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-#
  7. Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann Neurol, 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI

Cited by

See all 1,743

Metadata

Authors
Compston, A., & Coles, A.
Affiliations
University of Cambridge (GB)
Corresponding author
Compston, Alastair
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-04
Volume
359
Issue
9313
Pages
1221-1231
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4241890711
Cited by
1,743
References
78
Citations by year
2026: 22 · 2025: 32 · 2024: 45 · 2023: 44 · 2022: 61 · 2021: 80 · 2020: 87 · 2019: 68 · 2018: 78 · 2017: 92 · 2016: 106 · 2015: 94 · 2014: 101 · 2013: 92 · 2012: 105
FWCI
8.08
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
multiple sclerosis, autoimmune disease, neuroinflammation, environmental risk factors, genetic susceptibility, immune activation, axonal injury, neurodegeneration, relapse, disability progression, disease-modifying therapy, tissue repair
MeSH terms
Adult, Clinical Trials as Topic, Environment, Female, Humans, Male, Multiple Sclerosis, Risk Factors, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple sclerosis. https://app.cochat.ai/papers/10.1016/s0140-6736(02)08220-x
The paper
Compston, A., & Coles, A. (2002). Multiple sclerosis. The Lancet. https://doi.org/10.1016/s0140-6736(02)08220-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.